DAEJEON, South Korea--(BUSINESS WIRE)--Established in 1976, the Electronics and Telecommunications Research Institute (ETRI) in Daejeon, South Korea, is the government-sponsored R&D institute in the area of information, communications, electronics, broadcasting, and convergence technologies. Over 2,600 researchers and staff members are hard at work contributing to the growth of Korea’s economy.
Today, ETRI is focusing on AI-driven technologies. According to the 2019 WIPO Technology Trends Report, ETRI ranked 2nd globally in AI patent applications among top universities and public organizations. (www.wipo.int/wipo_magazine/en/2019/01/article_0001.html)
ETRI is actively involved in strategic technology licensing to move research innovations to public market. ETRI Holdings and ETRI’s internal technology licensing office (TLO) collaborate to incubate startups using ETRI technology until they are ready for IPO or M&A. Successful startup investments include Optella Inc. (https://www.cosemi.com/optella/), Syntekabio (www.syntekabio.com/eng/), Sugentech (www.sugentech.com/main.php), Genesystem (www.genesystem.co.kr/), and Minds Lab (mindslab.ai:8080/en).
To foster global collaboration, ETRI’s USA R&D center in Silicon Valley is actively seeking partnerships between Korea and leading players in the US. ETRI plans to present recent research and TLO activities in the US-Korea Conference (UKC2021, ukc.ksea.org/ukc2021/), which will be held December 15 – 18, 2021, in Garden Grove, near Los Angeles, California.
For more information about ETRI, please visit www.etri.re.kr/eng/main/main.etri.
